Search Results - "Kaleda, V G"

Refine Results
  1. 1

    Inflammatory markers and indicators of systemic endotoxemia in patients with treatment-resistant schizophrenia by Zozulya, S A, Otman, I N, Anikhovskaya, I A, Tikhonov, D V, Kaleda, V G, Yakovlev, M Y, Klyushnik, T P

    Published in European psychiatry (01-03-2023)
    “…IntroductionElevated levels of lipopolysaccharide (LPS) in circulation support chronic inflammation, which is involved in the pathological process in the brain…”
    Get full text
    Journal Article
  2. 2

    Assessing the impact of the de novo SLC6A1 mutation in schizophrenia through a comprehensive case study by Kondratyev, NV, Alfimova, MV, Kaleda, VG, Lezheiko, TV, Mikhailova, VA, Karpov, DS, Ublinsky, MV, Ushakov, VL, Lebedeva, IS, Golimbet, VE

    Published in Psychiatry research (01-09-2023)
    “…•The patient with an SLC6A1 mutation, typically linked to disorders like epilepsy and autism, exhibited symptoms consistent with schizophrenia and bipolar…”
    Get full text
    Journal Article
  3. 3

    Thermal Balance of the Brain and Markers of Inflammatory Response in Patients with Schizophrenia by Zozulya, S. A., Shevelev, O. A., Tikhonov, D. V., Simonov, A. N., Kaleda, V. G., Klyushnik, T. P., Petrova, M. V., Mengistu, E. M.

    “…In patients with schizophrenia, the thermal balance of the cerebral cortex was studied by means of microwave radiothermometry method and compared with the…”
    Get full text
    Journal Article
  4. 4

    MicroRNA in schizophrenia: genetic and expression analysis of miR-130b (22q11) by Burmistrova, O A, Goltsov, A Y, Abramova, L I, Kaleda, V G, Orlova, V A, Rogaev, E I

    Published in Biochemistry (Moscow) (01-05-2007)
    “…MicroRNAs (miRNAs) are a class of small regulatory RNAs that control a level of expression of protein encoding genes. Their role in brain pathologies is…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Assessment of the Initial Period of Schizotypal Disorder in Childhood by Goryunov, A. V., Kaleda, V. G.

    Published in Neuroscience and behavioral physiology (01-02-2023)
    “…Objectives . To establish the developmental features, family history, social adaptation, and structure of early psychopathological disorders in pediatric…”
    Get full text
    Journal Article
  7. 7

    Dynamics of Postpsychotic Depression in Adolescence by Kaleda, V. G., Tikhonov, D. V.

    Published in Neuroscience and behavioral physiology (01-02-2023)
    “…Objectives . To identify the psychopathological features of postpsychotic depression forming as part of the development of remission after first psychotic…”
    Get full text
    Journal Article
  8. 8

    Immunological predictors of rhythmic transcranial magnetic stimulation (rTMS) efficiency in patients with treatment-resistant schizophrenia by Zozulya, S A, Pomytkin, A N, Tikhonov, D V, Kaleda, V G, Klyushnik, T P

    Published in European psychiatry (01-08-2024)
    “…IntroductionModel and clinical studies demonstrate the efficiency of rhythmic transcranial magnetic stimulation (rTMS) in diseases associated with…”
    Get full text
    Journal Article
  9. 9

    Features of the inflammatory response at the long-term stages of juvenile schizophrenia by Zozulya, S. A., Golubev, S. A., Tikhonov, D. V., Kaleda, V. G., Klyushnik, T. P.

    Published in European psychiatry (19-07-2023)
    “…Introduction Immunological study of late stages of schizophrenia manifesting in young adult age is of considerable interest for clarification of pathogenetic…”
    Get full text
    Journal Article
  10. 10

    Application of a Biofeedback Method in the Treatment of Depression by Migalina, V. V., Omelchenko, M. A., Lebedeva, I. S., Kaleda, V. G.

    Published in Neuroscience and behavioral physiology (01-05-2024)
    “…With the aim of systematizing scientific data in the current Russian and foreign literature on the efficacy of biofeedback (BF) in the treatment of patients…”
    Get full text
    Journal Article
  11. 11

    Features of the spectrum of immune markers in patients with juvenile depression with clinically high risk of psychosis by Zozulya, S A, Omelchenko, M A, Otman, I N, Sarmanova, Z V, Migalina, V V, Kaleda, V G, Klyushnik, T P

    Published in European psychiatry (01-08-2024)
    “…IntroductionIdentification of biomarkers associated with the risk of psychosis manifestation in juvenile patients with depression may contribute to a better…”
    Get full text
    Journal Article
  12. 12

    Impaired monocyte activation in schizophrenia: ultrastructural abnormalities and increased IL-1β production by Uranova, Natalya A., Bonartsev, P. D., Androsova, L. V., Rakhmanova, V. I., Kaleda, V. G.

    “…Monocyte activation is consistently reported in patients with schizophrenia (SZ). We aimed to study the ultrastructure of monocytes and monocyte production of…”
    Get full text
    Journal Article
  13. 13

    Structural Features of the Brain in Juvenile Depression with Clinical High Risk of Psychosis by Dudina, A. N., Tomyshev, A. S., Omelchenko, M. A., Kaleda, V. G., Lebedeva, I. S.

    “…Objectives . To identify the structural features of the gray matter of the cerebral cortex in patients with depression at clinical high risk of psychosis…”
    Get full text
    Journal Article
  14. 14

    The serotonin transporter gene 5-HTTLPR polymorphism is associated with affective psychoses but not with schizophrenia: A large-scale study in the Russian population by Golimbet, Vera, Korovaitseva, Galina, Lezheiko, Tatyana, Abramova, L.I, Kaleda, V.G

    Published in Journal of affective disorders (15-01-2017)
    “…Abstract Background Affective syndrome is thought to be a key feature that differentiates schizophrenia from schizoaffective disorder (SA) and bipolar disorder…”
    Get full text
    Journal Article
  15. 15

    Supportive evidence for the association between the T102C 5-HTR2A gene polymorphism and schizophrenia: A large-scale case–control and family-based study by Golimbet, V.E, Lavrushina, O.M, Kaleda, V.G, Abramova, L.I, Lezheiko, T.V

    Published in European psychiatry (01-04-2007)
    “…Abstract Serotonin type 2A receptors (5-HTR2A) have long been implicated in schizophrenia pathology. A decreased number of these receptors were found in…”
    Get full text
    Journal Article
  16. 16

    The Clinical Course and Prognostic Problems of Youth Depressions with Attenuated Schizophrenic Symptoms by Kaleda, V. G., Omelchenko, M. A.

    “…Objective Clinical and follow-up verification of Attenuated Schizophrenic Symptoms (ASS) in the first youth depressive episode as early markers of the…”
    Get full text
    Journal Article
  17. 17

    Neuroimaging (Resting-State fMRI) and Neuropsychological Characteristics of Non-Converted Patients from a Group at Clinical High Risk for Schizophrenia by Lebedeva, I. S., Panikratova, Ya. R., Abdullina, E. G., Migalina, V. V., Tikhonov, D. V., Omelchenko, M. A., Kaleda, V. G.

    Published in Neuroscience and behavioral physiology (01-10-2023)
    “…The aim of the present study was, within the framework of the concept of “clinical high risk for psychosis,” to identify functional characteristics of the…”
    Get full text
    Journal Article
  18. 18

    Clinical and Pathopsychological Characteristics of Juvenile Depression with Attenuated Schizophrenic Spectrum Symptoms by Omelchenko, M. A., Atadzhykova, Yu. A., Migalina, V. V., Nikiforova, I. Yu, Kaleda, V. G.

    Published in Neuroscience and behavioral physiology (01-03-2022)
    “…Objectives. To identify the clinical and pathopsychological features of juvenile depression with attenuated schizophrenia spectrum symptoms, as well as their…”
    Get full text
    Journal Article
  19. 19

    Dynamics of autoagressive behavior in youth in the trajectory of borderline personality disorder by Kuleshov, A. A., Krylova, E. S., Beburishvili, A. A., Kaleda, V. G.

    “…   Objective:  to determinate the clinical and psychopathological characteristics of autoagressive behavior (AB) in youth in the trajectory of borderline…”
    Get full text
    Journal Article
  20. 20

    Prognostication of Functional Outcomes of Schizophrenia Using a Multigene Panel by Golubev, S. A., Lezheiko, T. V., Korovaitseva, G. I., Gabaeva, M. V., Kolesina, N. Yu, Kaleda, V. G., Golimbet, V. E.

    Published in Neuroscience and behavioral physiology (01-05-2022)
    “…Objectives. To compare groups of schizophrenia patients with different levels of functional outcomes and different frequencies of risk variants at polymorphic…”
    Get full text
    Journal Article